Ngadikun , Pradjatmo H, Nugroho K, Pasala M, Prasetyastuti
J Cancer. 2023; 14(12):2173-2180.
PMID: 37576394
PMC: 10414036.
DOI: 10.7150/jca.82941.
Robotti M, Scebba F, Angeloni D
Biomedicines. 2023; 11(3).
PMID: 36979630
PMC: 10044752.
DOI: 10.3390/biomedicines11030652.
Piatek K, Schepelmann M, Kallay E
Nutrients. 2022; 14(18).
PMID: 36145244
PMC: 9501475.
DOI: 10.3390/nu14183867.
Singh T, Neal A, DiBernardo G, Raheseparian N, Moatamed N, Memarzadeh S
Int J Oncol. 2022; 60(3).
PMID: 35191515
PMC: 8878637.
DOI: 10.3892/ijo.2022.5325.
Godkhindi V, Gupta N, Pai A, Ahamed M A A, Saravu K
Cureus. 2021; 13(8):e17503.
PMID: 34595075
PMC: 8467808.
DOI: 10.7759/cureus.17503.
Diagnostic accuracy of F-FDG PET/CT scan for peritoneal metastases in advanced ovarian cancer.
Feng Z, Liu S, Ju X, Chen X, Li R, Bi R
Quant Imaging Med Surg. 2021; 11(8):3392-3398.
PMID: 34341717
PMC: 8245942.
DOI: 10.21037/qims-20-784.
: A Systematic Review.
Han Y, Jiang L, Liu K, Ouyang L, Li Y
Front Oncol. 2021; 11:703949.
PMID: 34307173
PMC: 8295753.
DOI: 10.3389/fonc.2021.703949.
Evolution of core archetypal phenotypes in progressive high grade serous ovarian cancer.
Nath A, Cosgrove P, Mirsafian H, Christie E, Pflieger L, Copeland B
Nat Commun. 2021; 12(1):3039.
PMID: 34031395
PMC: 8144406.
DOI: 10.1038/s41467-021-23171-3.
Homologous recombination repair gene mutations show no survival benefits in Chinese high-grade serous ovarian cancer patients.
Feng Z, Wen H, Ju X, Bi R, Chen X, Yang W
Ann Transl Med. 2021; 9(5):364.
PMID: 33842585
PMC: 8033363.
DOI: 10.21037/atm-20-5136.
Evaluating the effect of an educational program on increasing cervical cancer screening behavior among women in Fasa, Iran.
Sarvestani M, Jeihooni A, Moradi Z, Dehghan A
BMC Womens Health. 2021; 21(1):41.
PMID: 33509175
PMC: 7844982.
DOI: 10.1186/s12905-021-01191-x.
: The Implications of Direct Intercellular Communication Tunneling Nanotubes in Peritoneal and Other Invasive Malignancies.
Lou E
Front Oncol. 2020; 10:559548.
PMID: 33324545
PMC: 7727447.
DOI: 10.3389/fonc.2020.559548.
Toll-like receptor 2 activation induces C-C chemokine receptor 2-dependent natural killer cell recruitment to the peritoneum.
Haidl I, Meghnem D, Issekutz T, Marshall J
Immunol Cell Biol. 2020; 98(10):854-867.
PMID: 32696994
PMC: 7754274.
DOI: 10.1111/imcb.12379.
The Influence of "Omental Cake" Presence on the Completeness of Cytoreduction in Advanced-stage Ovarian Cancer.
Bacalbasa N, Diaconu C, Iliescu L, Savu C, Bratu O, Bolca C
In Vivo. 2020; 34(4):2187-2191.
PMID: 32606203
PMC: 7439871.
DOI: 10.21873/invivo.12028.
Sentinel lymph node technique in early-stage ovarian cancer (SENTOV): a phase II clinical trial.
Lago V, Bello P, Montero B, Matute L, Padilla-Iserte P, Lopez S
Int J Gynecol Cancer. 2020; 30(9):1390-1396.
PMID: 32448808
PMC: 7497563.
DOI: 10.1136/ijgc-2020-001289.
miR‑508‑3p suppresses the development of ovarian carcinoma by targeting CCNA2 and MMP7.
Guo F, Zhang K, Li M, Cui L, Liu G, Yan Y
Int J Oncol. 2020; 57(1):264-276.
PMID: 32377701
PMC: 7252466.
DOI: 10.3892/ijo.2020.5055.
High-grade serous ovarian and fallopian tube carcinomas with similar clinicopathological characteristics might originate from serous tubal intraepithelial carcinoma in Chinese women.
Wang J, Wu H, Zhang Y, Zhang Y, Li X, Zhao Q
Int J Clin Exp Pathol. 2020; 10(8):8222-8232.
PMID: 31966673
PMC: 6965390.
Ovarian Cancer Dissemination-A Cell Biologist's Perspective.
Farsinejad S, Cattabiani T, Muranen T, Iwanicki M
Cancers (Basel). 2019; 11(12).
PMID: 31817625
PMC: 6966436.
DOI: 10.3390/cancers11121957.
Therapeutic Inducers of Apoptosis in Ovarian Cancer.
Binju M, Amaya-Padilla M, Wan G, Gunosewoyo H, Suryo Rahmanto Y, Yu Y
Cancers (Basel). 2019; 11(11).
PMID: 31766284
PMC: 6896143.
DOI: 10.3390/cancers11111786.
MicroRNA-331-3p inhibits proliferation and metastasis of ovarian cancer by targeting RCC2.
Buranjiang G, Kuerban R, Abuduwanke A, Li X, Kuerban G
Arch Med Sci. 2019; 15(6):1520-1529.
PMID: 31749881
PMC: 6855167.
DOI: 10.5114/aoms.2018.77858.
A new pathogenic mutation of the BRCA1 gene in a patient with ovarian cancer: A case report.
Yizhen N, Kemin L, Qingli L, Danqing W, Rutie Y, Liang S
Medicine (Baltimore). 2018; 97(38):e12371.
PMID: 30235698
PMC: 6160123.
DOI: 10.1097/MD.0000000000012371.
